Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
0.8827
+0.1017 (13.02%)
At close: May 12, 2025, 4:00 PM
0.9000
+0.0173 (1.96%)
After-hours: May 12, 2025, 6:38 PM EDT

Prelude Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net Income
-127.83-127.17-121.83-115.44-111.69-56.93
Upgrade
Depreciation & Amortization
1.781.771.171.320.920.54
Upgrade
Loss (Gain) From Sale of Assets
-----0.01
Upgrade
Loss (Gain) From Sale of Investments
-3.02-4.64-3.472.591.36-
Upgrade
Stock-Based Compensation
19.6321.3525.6225.1420.935.58
Upgrade
Other Operating Activities
1.561.591.941.721.33-
Upgrade
Change in Accounts Payable
0.763.31-2.27-0.353.91.16
Upgrade
Change in Other Net Operating Assets
1.780.91-8.211.28-0.283.46
Upgrade
Operating Cash Flow
-105.33-102.89-107.06-83.73-83.53-46.18
Upgrade
Capital Expenditures
-0.52-0.76-3.51-3.02-2.32-0.62
Upgrade
Investment in Securities
121.6890.96-31.1384.71-261.48-
Upgrade
Investing Cash Flow
121.1690.19-34.6581.69-263.8-0.62
Upgrade
Long-Term Debt Repaid
--0.4----0.26
Upgrade
Net Debt Issued (Repaid)
-0.55-0.4----0.26
Upgrade
Issuance of Common Stock
0.440.44136.410.82165.2166.73
Upgrade
Repurchase of Common Stock
-0.04-0.05-0.02---
Upgrade
Other Financing Activities
-0.11-0.11---0.3-0.01
Upgrade
Financing Cash Flow
-0.27-0.12136.40.82164.9246.23
Upgrade
Net Cash Flow
15.56-12.82-5.31-1.22-182.44199.43
Upgrade
Free Cash Flow
-105.85-103.65-110.58-86.75-85.85-46.8
Upgrade
Free Cash Flow Margin
-1512.14%-1480.74%----
Upgrade
Free Cash Flow Per Share
-1.40-1.37-1.83-1.83-1.86-3.75
Upgrade
Levered Free Cash Flow
-64.8-62-58.93-50.12-46.86-25.58
Upgrade
Unlevered Free Cash Flow
-64.8-62-58.93-50.12-46.86-25.58
Upgrade
Change in Net Working Capital
-1.79-2.97-0.48-3.64-4.7-5.64
Upgrade
Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q